NOS3 and acute coronary syndrome: Previous study showed that MPs derived from acute coronary syndrome (ACS) patients attenuated endothelial-dependent vasodilatation, reduced NO expression and eNOS phosphorylation and decreased the interaction between eNOS and Hsp90, while increasing O2− generation (Han et al., 2015; Wang et al., 2021).